Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Individual risk management strategy for SARS-CoV-2 infection: A step toward personalized healthcare
SARS-CoV-2 antibody testing—questions to be asked
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
